ProPhase Labs
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ProPhase Labs and other ETFs, options, and stocks.About PRPH
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment.
PRPH Key Statistics
Stock Snapshot
As of today, ProPhase Labs(PRPH) shares are valued at $0.20. The company's market cap stands at 7.97M, with a P/E ratio of -0.13.
On 2025-11-23, ProPhase Labs(PRPH) stock traded between a low of $0.18 and a high of $0.21. Shares are currently priced at $0.20, which is +9.6% above the low and -2.4% below the high.
ProPhase Labs(PRPH) shares are trading with a volume of 1.28M, against a daily average of 1.25M.
In the last year, ProPhase Labs(PRPH) shares hit a 52-week high of $0.93 and a 52-week low of $0.18.
In the last year, ProPhase Labs(PRPH) shares hit a 52-week high of $0.93 and a 52-week low of $0.18.
PRPH News
Prophase Labs ((PRPH)) has held its Q3 earnings call. Read on for the main highlights of the call. TipRanks Black Friday Sale Claim 60% off TipRanks Premium for...
Earnings Call Insights ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances Nov. 19, 2025 5:04 PM ET...
TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to Tip...
More PRPH News
Reports Q3 revenue $0.9M vs. $1.4M last year.”The public markets are not yet reflecting the true value of ProPhase or the multi-year opportunities now in front...
ProPhase Labs (PRPH) announced it is in M&A related discussions not connected to a crypto treasury strategy. These discussions, if successful, could potentially...